Home  >  News
  Novartis to present 5-year data of extended phase III studies of Cosentyx in PsA & AS patients,   October 17, 2018
  PRC NMPA approves JHL Biotech's phase I and phase III clinical trial application for biosimilar JHL1149 to treat cancer,   October 16, 2018
  Bluegrass Vascular completes enrollment of international SAVE registry with positive results,   October 16, 2018
  Targovax announces encouraging disease-free survival data from Tg01 clinical trial in resected pancreatic cancer,   October 16, 2018
  PureTech’s Karuna initiates phase 2 study of KarXT for treatment of Schizophrenia,   October 16, 2018
  Bristol-Myers Squibb's phase 3 CheckMate-331 study does not meet primary endpont,   October 15, 2018
  Pharmaxis announces positive results from phase 1 trial for LOXL2 inhibitor compound to treat fibrotic diseases,   October 15, 2018
  Oncolytics Biotech announces publication of positive results for pelareorep in abstract for ESMO 2018 Congress,   October 15, 2018
  Theravance Biopharma, Mylan present positive data from multiple studies of Yupelri at 2018 CHEST meeting,   October 13, 2018
  Bristol-Myers Squibb, Compugen ink clinical collaboration to evaluate COM701 in combo with Opdivo to treat advanced solid tumours,   October 13, 2018
  MEI Pharma, BeiGene ink clinical collaboration to evaluate ME-401 in combo with zanubrutinib to treat B-cell malignancies,   October 12, 2018
  Novartis phase IIIb ASSESS study of Gilenya 0.5mg meets primary endpoint of significantly reducing ARR compared to Copaxone in RRMS,   October 12, 2018
  NeuroVive receives UK MHRA approval to begin phase I KL1333 study to treat mitochondrial disease,   October 11, 2018
  AstraZeneca presents advances in improving treatment options for ovarian, lung cancer patients at ESMO 2018 Congress,   October 11, 2018
  Exelixis begins phase 3 trial of cabozantinib in radioiodine-refractory DTC patients who have progressed after prior VEGFR-targeted therapies,   October 10, 2018
  Roche to present positive data from broad cancer immunotherapy programme and across a wide range of cancers at ESMO 2018 Congress,   October 10, 2018
  PTC Therapeutics announces data from patient registry demonstrating Translarna slows disease progression in children with Duchenne caused by nonsense mutation,   October 09, 2018
  Theravance Biopharma presents positive new data from multiple studies of Vibativ at IDWeek 2018,   October 09, 2018
  V-Wave begins patient enrollment in RELIEVE-HF pivotal trial of heart failure therapy,   October 08, 2018
  BerGenBio begins second stage of phase II trial of selective AXL inhibitor bemcentinib in combo with Keytruda in NSCLC patients,   October 08, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |